Cumberland Pharmaceuticals
CPIX
29 hedge funds and large institutions have $8.97M invested in Cumberland Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.
175% more call options, than puts
Call options by funds: $399K | Put options by funds: $145K
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
7% more funds holding
Funds holding: 27 → 29 (+2)
1.31% less ownership
Funds ownership: 19.77% → 18.46% (-1.3%)
24% less capital invested
Capital invested by funds: $11.8M → $8.97M (-$2.8M)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$140K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$92.5K |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$78K |
| 4 |
Jane Street
New York
|
+$56.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$555K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$192K |
| 3 |
HBCM
Heron Bay Capital Management
Bloomfield Hills,
Michigan
|
-$116K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$100K |
| 5 |
Bank of New York Mellon
New York
|
-$54.2K |
CPIX Hedge Fund Activity: Q1 2026 in Review
29 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2026, worth a combined $8.97M — down 24% from $11.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CPIX positions and 6 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Marex Group, opening a new position worth an estimated $140K. The largest seller was Perceptive Advisors, cutting an estimated $555K.
- 29 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2026, up from 27 in Q4 2025.
- Funds reported $8.97M of Cumberland Pharmaceuticals stock for Q1 2026, down 24% quarter-over-quarter.
- 9 funds opened new Cumberland Pharmaceuticals positions in Q1 2026 and 6 closed out, a net change of +3 holders.
- The largest Cumberland Pharmaceuticals buyer in Q1 2026 was Marex Group, an estimated $140K added.
- The largest Cumberland Pharmaceuticals seller in Q1 2026 was Perceptive Advisors, an estimated $555K sold.
Based on aggregated 13F filings for Q1 2026.